nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyzine—CYP2D6—Gefitinib—lung cancer	0.285	0.32	CbGbCtD
Hydroxyzine—CYP2D6—Vinorelbine—lung cancer	0.22	0.246	CbGbCtD
Hydroxyzine—CYP2D6—Erlotinib—lung cancer	0.169	0.189	CbGbCtD
Hydroxyzine—CYP2D6—Vinblastine—lung cancer	0.135	0.152	CbGbCtD
Hydroxyzine—CYP2D6—Doxorubicin—lung cancer	0.0831	0.0932	CbGbCtD
Hydroxyzine—Flunarizine—CYP2A6—lung cancer	0.00201	0.256	CrCbGaD
Hydroxyzine—Dry mouth—Gefitinib—lung cancer	0.00182	0.0278	CcSEcCtD
Hydroxyzine—Hypotension—Gefitinib—lung cancer	0.00167	0.0255	CcSEcCtD
Hydroxyzine—Cinnarizine—CYP2A6—lung cancer	0.00159	0.203	CrCbGaD
Hydroxyzine—Urticaria—Pemetrexed—lung cancer	0.00142	0.0218	CcSEcCtD
Hydroxyzine—Stupor—Methotrexate—lung cancer	0.00142	0.0218	CcSEcCtD
Hydroxyzine—Urticaria—Gefitinib—lung cancer	0.00142	0.0217	CcSEcCtD
Hydroxyzine—Flunarizine—CYP1A1—lung cancer	0.00141	0.18	CrCbGaD
Hydroxyzine—Hypotension—Teniposide—lung cancer	0.00136	0.0208	CcSEcCtD
Hydroxyzine—Hypersensitivity—Pemetrexed—lung cancer	0.00132	0.0202	CcSEcCtD
Hydroxyzine—Hypersensitivity—Gefitinib—lung cancer	0.00131	0.0201	CcSEcCtD
Hydroxyzine—Rash—Crizotinib—lung cancer	0.00124	0.0189	CcSEcCtD
Hydroxyzine—Dermatitis—Crizotinib—lung cancer	0.00124	0.0189	CcSEcCtD
Hydroxyzine—Convulsion—Vinblastine—lung cancer	0.00118	0.018	CcSEcCtD
Hydroxyzine—Urticaria—Teniposide—lung cancer	0.00115	0.0177	CcSEcCtD
Hydroxyzine—Rash—Pemetrexed—lung cancer	0.00113	0.0173	CcSEcCtD
Hydroxyzine—Dermatitis—Pemetrexed—lung cancer	0.00113	0.0173	CcSEcCtD
Hydroxyzine—Rash—Gefitinib—lung cancer	0.00112	0.0172	CcSEcCtD
Hydroxyzine—Dermatitis—Gefitinib—lung cancer	0.00112	0.0172	CcSEcCtD
Hydroxyzine—Cinnarizine—CYP1A1—lung cancer	0.00111	0.142	CrCbGaD
Hydroxyzine—Hypersensitivity—Teniposide—lung cancer	0.00107	0.0164	CcSEcCtD
Hydroxyzine—Depressed level of consciousness—Methotrexate—lung cancer	0.00102	0.0157	CcSEcCtD
Hydroxyzine—Rash—Teniposide—lung cancer	0.000916	0.014	CcSEcCtD
Hydroxyzine—Dermatitis—Teniposide—lung cancer	0.000915	0.014	CcSEcCtD
Hydroxyzine—Headache—Teniposide—lung cancer	0.00091	0.0139	CcSEcCtD
Hydroxyzine—Hypotension—Vinorelbine—lung cancer	0.000861	0.0132	CcSEcCtD
Hydroxyzine—Urticaria—Topotecan—lung cancer	0.000855	0.0131	CcSEcCtD
Hydroxyzine—Hypersensitivity—Vinblastine—lung cancer	0.000817	0.0125	CcSEcCtD
Hydroxyzine—Hypersensitivity—Topotecan—lung cancer	0.000793	0.0121	CcSEcCtD
Hydroxyzine—Tremor—Cisplatin—lung cancer	0.000792	0.0121	CcSEcCtD
Hydroxyzine—Convulsion—Cisplatin—lung cancer	0.000732	0.0112	CcSEcCtD
Hydroxyzine—Urticaria—Vinorelbine—lung cancer	0.000732	0.0112	CcSEcCtD
Hydroxyzine—Tremor—Paclitaxel—lung cancer	0.000711	0.0109	CcSEcCtD
Hydroxyzine—Hypotension—Irinotecan—lung cancer	0.00071	0.0109	CcSEcCtD
Hydroxyzine—Headache—Vinblastine—lung cancer	0.000694	0.0106	CcSEcCtD
Hydroxyzine—Hypotension—Gemcitabine—lung cancer	0.000691	0.0106	CcSEcCtD
Hydroxyzine—Nefazodone—ABCB1—lung cancer	0.000685	0.0875	CrCbGaD
Hydroxyzine—Rash—Topotecan—lung cancer	0.000679	0.0104	CcSEcCtD
Hydroxyzine—Hypersensitivity—Vinorelbine—lung cancer	0.000679	0.0104	CcSEcCtD
Hydroxyzine—Dermatitis—Topotecan—lung cancer	0.000678	0.0104	CcSEcCtD
Hydroxyzine—Somnolence—Irinotecan—lung cancer	0.000675	0.0103	CcSEcCtD
Hydroxyzine—Headache—Topotecan—lung cancer	0.000675	0.0103	CcSEcCtD
Hydroxyzine—Rash—Erlotinib—lung cancer	0.000672	0.0103	CcSEcCtD
Hydroxyzine—Dermatitis—Erlotinib—lung cancer	0.000671	0.0103	CcSEcCtD
Hydroxyzine—Convulsion—Etoposide—lung cancer	0.000671	0.0103	CcSEcCtD
Hydroxyzine—Headache—Erlotinib—lung cancer	0.000667	0.0102	CcSEcCtD
Hydroxyzine—Somnolence—Gemcitabine—lung cancer	0.000658	0.0101	CcSEcCtD
Hydroxyzine—Convulsion—Paclitaxel—lung cancer	0.000658	0.0101	CcSEcCtD
Hydroxyzine—Hypotension—Cisplatin—lung cancer	0.000644	0.00987	CcSEcCtD
Hydroxyzine—Trazodone—ABCB1—lung cancer	0.000634	0.081	CrCbGaD
Hydroxyzine—Dry mouth—Paclitaxel—lung cancer	0.000632	0.00968	CcSEcCtD
Hydroxyzine—Drowsiness—Methotrexate—lung cancer	0.000593	0.00909	CcSEcCtD
Hydroxyzine—Hypotension—Etoposide—lung cancer	0.00059	0.00904	CcSEcCtD
Hydroxyzine—Rash—Vinorelbine—lung cancer	0.000581	0.00889	CcSEcCtD
Hydroxyzine—Dermatitis—Vinorelbine—lung cancer	0.00058	0.00888	CcSEcCtD
Hydroxyzine—Hypotension—Paclitaxel—lung cancer	0.000579	0.00886	CcSEcCtD
Hydroxyzine—Headache—Vinorelbine—lung cancer	0.000577	0.00884	CcSEcCtD
Hydroxyzine—Somnolence—Etoposide—lung cancer	0.000562	0.0086	CcSEcCtD
Hydroxyzine—Hypersensitivity—Irinotecan—lung cancer	0.00056	0.00857	CcSEcCtD
Hydroxyzine—Convulsion—Docetaxel—lung cancer	0.000557	0.00854	CcSEcCtD
Hydroxyzine—Somnolence—Paclitaxel—lung cancer	0.000551	0.00843	CcSEcCtD
Hydroxyzine—Dry mouth—Docetaxel—lung cancer	0.000536	0.0082	CcSEcCtD
Hydroxyzine—Drowsiness—Doxorubicin—lung cancer	0.000514	0.00787	CcSEcCtD
Hydroxyzine—Hypersensitivity—Cisplatin—lung cancer	0.000508	0.00778	CcSEcCtD
Hydroxyzine—Urticaria—Etoposide—lung cancer	0.000502	0.00769	CcSEcCtD
Hydroxyzine—Urticaria—Paclitaxel—lung cancer	0.000492	0.00754	CcSEcCtD
Hydroxyzine—Hypotension—Docetaxel—lung cancer	0.000491	0.00751	CcSEcCtD
Hydroxyzine—Rash—Irinotecan—lung cancer	0.000479	0.00733	CcSEcCtD
Hydroxyzine—Dermatitis—Irinotecan—lung cancer	0.000479	0.00733	CcSEcCtD
Hydroxyzine—Headache—Irinotecan—lung cancer	0.000476	0.00729	CcSEcCtD
Hydroxyzine—Somnolence—Docetaxel—lung cancer	0.000467	0.00715	CcSEcCtD
Hydroxyzine—Rash—Gemcitabine—lung cancer	0.000467	0.00714	CcSEcCtD
Hydroxyzine—Dermatitis—Gemcitabine—lung cancer	0.000466	0.00714	CcSEcCtD
Hydroxyzine—Hypersensitivity—Etoposide—lung cancer	0.000466	0.00713	CcSEcCtD
Hydroxyzine—Headache—Gemcitabine—lung cancer	0.000464	0.0071	CcSEcCtD
Hydroxyzine—Hypersensitivity—Paclitaxel—lung cancer	0.000456	0.00699	CcSEcCtD
Hydroxyzine—Rash—Cisplatin—lung cancer	0.000435	0.00666	CcSEcCtD
Hydroxyzine—Dermatitis—Cisplatin—lung cancer	0.000434	0.00665	CcSEcCtD
Hydroxyzine—Convulsion—Methotrexate—lung cancer	0.000402	0.00615	CcSEcCtD
Hydroxyzine—Rash—Etoposide—lung cancer	0.000398	0.0061	CcSEcCtD
Hydroxyzine—Quetiapine—ABCB1—lung cancer	0.000398	0.0509	CrCbGaD
Hydroxyzine—Dermatitis—Etoposide—lung cancer	0.000398	0.00609	CcSEcCtD
Hydroxyzine—Headache—Etoposide—lung cancer	0.000396	0.00606	CcSEcCtD
Hydroxyzine—Rash—Paclitaxel—lung cancer	0.000391	0.00598	CcSEcCtD
Hydroxyzine—Dermatitis—Paclitaxel—lung cancer	0.00039	0.00598	CcSEcCtD
Hydroxyzine—Headache—Paclitaxel—lung cancer	0.000388	0.00594	CcSEcCtD
Hydroxyzine—Hypersensitivity—Docetaxel—lung cancer	0.000387	0.00592	CcSEcCtD
Hydroxyzine—Hypotension—Methotrexate—lung cancer	0.000354	0.00542	CcSEcCtD
Hydroxyzine—Convulsion—Doxorubicin—lung cancer	0.000348	0.00533	CcSEcCtD
Hydroxyzine—Somnolence—Methotrexate—lung cancer	0.000336	0.00515	CcSEcCtD
Hydroxyzine—Dry mouth—Doxorubicin—lung cancer	0.000334	0.00512	CcSEcCtD
Hydroxyzine—Rash—Docetaxel—lung cancer	0.000331	0.00507	CcSEcCtD
Hydroxyzine—Dermatitis—Docetaxel—lung cancer	0.000331	0.00507	CcSEcCtD
Hydroxyzine—Headache—Docetaxel—lung cancer	0.000329	0.00504	CcSEcCtD
Hydroxyzine—Hypotension—Doxorubicin—lung cancer	0.000306	0.00469	CcSEcCtD
Hydroxyzine—Urticaria—Methotrexate—lung cancer	0.000301	0.0046	CcSEcCtD
Hydroxyzine—Somnolence—Doxorubicin—lung cancer	0.000291	0.00446	CcSEcCtD
Hydroxyzine—Hypersensitivity—Methotrexate—lung cancer	0.000279	0.00427	CcSEcCtD
Hydroxyzine—Urticaria—Doxorubicin—lung cancer	0.00026	0.00399	CcSEcCtD
Hydroxyzine—Hypersensitivity—Doxorubicin—lung cancer	0.000241	0.0037	CcSEcCtD
Hydroxyzine—Rash—Methotrexate—lung cancer	0.000239	0.00365	CcSEcCtD
Hydroxyzine—Dermatitis—Methotrexate—lung cancer	0.000238	0.00365	CcSEcCtD
Hydroxyzine—Headache—Methotrexate—lung cancer	0.000237	0.00363	CcSEcCtD
Hydroxyzine—HRH1—G alpha (q) signalling events—GNG11—lung cancer	0.000231	0.00656	CbGpPWpGaD
Hydroxyzine—HRH1—IL-4 Signaling Pathway—PIK3CD—lung cancer	0.000222	0.0063	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—lung cancer	0.000221	0.00627	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OXTR—lung cancer	0.000221	0.00627	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—CYP2A7—lung cancer	0.000214	0.00607	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—CYP2A7—lung cancer	0.000211	0.00598	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNG11—lung cancer	0.000207	0.00587	CbGpPWpGaD
Hydroxyzine—Rash—Doxorubicin—lung cancer	0.000207	0.00316	CcSEcCtD
Hydroxyzine—Dermatitis—Doxorubicin—lung cancer	0.000206	0.00316	CcSEcCtD
Hydroxyzine—Headache—Doxorubicin—lung cancer	0.000205	0.00314	CcSEcCtD
Hydroxyzine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000199	0.00564	CbGpPWpGaD
Hydroxyzine—HRH1—GPCRs, Class A Rhodopsin-like—OXTR—lung cancer	0.000191	0.00542	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—GSTA3—lung cancer	0.000191	0.00541	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—GSTA3—lung cancer	0.000188	0.00533	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—ANXA1—lung cancer	0.000182	0.00516	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—GIPR—lung cancer	0.000178	0.00505	CbGpPWpGaD
Hydroxyzine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000176	0.005	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—GSTA4—lung cancer	0.000174	0.00495	CbGpPWpGaD
Hydroxyzine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000174	0.00493	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—APP—lung cancer	0.000172	0.00489	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—GSTA4—lung cancer	0.000172	0.00488	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—GSTA2—lung cancer	0.00017	0.00482	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—GSTA1—lung cancer	0.000164	0.00465	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—GRP—lung cancer	0.000164	0.00464	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—OXTR—lung cancer	0.000164	0.00464	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—lung cancer	0.000163	0.00461	CbGpPWpGaD
Hydroxyzine—HRH1—IL-4 Signaling Pathway—EP300—lung cancer	0.00016	0.00453	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—AKR1C1—lung cancer	0.000155	0.00439	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—APP—lung cancer	0.000154	0.00437	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—UGT1A1—lung cancer	0.000152	0.00432	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—GRM8—lung cancer	0.000151	0.00429	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—UGT1A1—lung cancer	0.00015	0.00426	CbGpPWpGaD
Hydroxyzine—HRH1—IL-4 Signaling Pathway—STAT3—lung cancer	0.00015	0.00425	CbGpPWpGaD
Hydroxyzine—HRH1—IL-4 Signaling Pathway—MAPK3—lung cancer	0.000143	0.00406	CbGpPWpGaD
Hydroxyzine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000143	0.00405	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—AVP—lung cancer	0.000134	0.0038	CbGpPWpGaD
Hydroxyzine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000131	0.00373	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—HPGDS—lung cancer	0.00013	0.00368	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—GSTT1—lung cancer	0.000126	0.00356	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—OXTR—lung cancer	0.000125	0.00354	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—GRP—lung cancer	0.000125	0.00354	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—GCLC—lung cancer	0.000124	0.00352	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—CYP2A6—lung cancer	0.000124	0.00352	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—lung cancer	0.00012	0.00342	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—lung cancer	0.00012	0.0034	CbGpPWpGaD
Hydroxyzine—HRH1—IL-4 Signaling Pathway—PIK3CA—lung cancer	0.000118	0.00335	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—GNG11—lung cancer	0.000117	0.00331	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—APP—lung cancer	0.000114	0.00324	CbGpPWpGaD
Hydroxyzine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000107	0.00302	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—CYP2E1—lung cancer	0.000106	0.003	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—CYP2E1—lung cancer	0.000104	0.00296	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GIPR—lung cancer	0.000101	0.00285	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—PTHLH—lung cancer	9.76e-05	0.00277	CbGpPWpGaD
Hydroxyzine—HRH1—IL-4 Signaling Pathway—AKT1—lung cancer	9.65e-05	0.00274	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—ANXA1—lung cancer	9.17e-05	0.0026	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GIPR—lung cancer	9.14e-05	0.00259	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	8.88e-05	0.00252	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—GSTP1—lung cancer	8.71e-05	0.00247	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—APP—lung cancer	8.7e-05	0.00247	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—GSTP1—lung cancer	8.59e-05	0.00244	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GRM8—lung cancer	8.56e-05	0.00243	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—GSTM1—lung cancer	8.01e-05	0.00227	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	7.9e-05	0.00224	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—lung cancer	7.77e-05	0.0022	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GRM8—lung cancer	7.77e-05	0.0022	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—CYP1A1—lung cancer	7.59e-05	0.00215	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	7.49e-05	0.00212	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—lung cancer	7.41e-05	0.0021	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—AXL—lung cancer	7.12e-05	0.00202	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GRP—lung cancer	7.05e-05	0.002	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—OXTR—lung cancer	7.05e-05	0.002	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—AVP—lung cancer	6.76e-05	0.00192	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—COL4A3BP—lung cancer	6.68e-05	0.00189	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—AZIN2—lung cancer	6.68e-05	0.00189	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—GNG11—lung cancer	6.6e-05	0.00187	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	6.57e-05	0.00186	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—OXTR—lung cancer	6.4e-05	0.00181	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GRP—lung cancer	6.4e-05	0.00181	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—GNG11—lung cancer	5.99e-05	0.0017	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—ADCY1—lung cancer	5.93e-05	0.00168	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	5.9e-05	0.00167	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ATP5H—lung cancer	5.68e-05	0.00161	CbGpPWpGaD
Hydroxyzine—CYP2D6—Biological oxidations—POMC—lung cancer	5.66e-05	0.0016	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—COL4A2—lung cancer	5.54e-05	0.00157	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—PTHLH—lung cancer	5.51e-05	0.00156	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GIPR—lung cancer	5.4e-05	0.00153	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—ADCY1—lung cancer	5.39e-05	0.00153	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—PPP2R1B—lung cancer	5.25e-05	0.00149	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—ANXA1—lung cancer	5.18e-05	0.00147	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PLBD1—lung cancer	5.06e-05	0.00143	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—SDC4—lung cancer	5.04e-05	0.00143	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—PTHLH—lung cancer	5.01e-05	0.00142	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	4.95e-05	0.0014	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—DUSP3—lung cancer	4.94e-05	0.0014	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—APP—lung cancer	4.91e-05	0.00139	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—RHEB—lung cancer	4.84e-05	0.00137	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	4.74e-05	0.00134	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—ANXA1—lung cancer	4.71e-05	0.00133	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—HSD17B10—lung cancer	4.63e-05	0.00131	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GRM8—lung cancer	4.59e-05	0.0013	CbGpPWpGaD
Hydroxyzine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	4.56e-05	0.00129	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	4.51e-05	0.00128	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—POMC—lung cancer	4.49e-05	0.00127	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—APP—lung cancer	4.46e-05	0.00127	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—SKI—lung cancer	4.45e-05	0.00126	CbGpPWpGaD
Hydroxyzine—HRH1—G alpha (q) signalling events—PIK3CA—lung cancer	4.37e-05	0.00124	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CKB—lung cancer	4.3e-05	0.00122	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	4.26e-05	0.00121	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CNDP2—lung cancer	4.05e-05	0.00115	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GSTM2—lung cancer	4.05e-05	0.00115	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—MTMR3—lung cancer	3.94e-05	0.00112	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	3.91e-05	0.00111	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PXN—lung cancer	3.86e-05	0.00109	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PGAM1—lung cancer	3.84e-05	0.00109	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—AVP—lung cancer	3.82e-05	0.00108	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GRP—lung cancer	3.78e-05	0.00107	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—AKR1C1—lung cancer	3.78e-05	0.00107	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—OXTR—lung cancer	3.78e-05	0.00107	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CYP2A7—lung cancer	3.66e-05	0.00104	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	3.62e-05	0.00103	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—SDC4—lung cancer	3.58e-05	0.00102	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—GNG11—lung cancer	3.54e-05	0.001	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR ligand binding—CXCL8—lung cancer	3.48e-05	0.000986	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—AVP—lung cancer	3.47e-05	0.000984	CbGpPWpGaD
Hydroxyzine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	3.46e-05	0.000982	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—VEGFC—lung cancer	3.37e-05	0.000955	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GSTA3—lung cancer	3.26e-05	0.000925	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—RRM1—lung cancer	3.26e-05	0.000925	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ADCY1—lung cancer	3.18e-05	0.000902	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—SMARCA4—lung cancer	3.1e-05	0.000879	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PPP2R1B—lung cancer	3.1e-05	0.000879	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—B4GALT5—lung cancer	3.07e-05	0.000869	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—HSPB1—lung cancer	2.99e-05	0.000848	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GSTA4—lung cancer	2.98e-05	0.000846	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PTHLH—lung cancer	2.96e-05	0.000839	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GSTA2—lung cancer	2.91e-05	0.000824	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GSTA1—lung cancer	2.8e-05	0.000795	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ANXA1—lung cancer	2.78e-05	0.000788	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ABCC3—lung cancer	2.77e-05	0.000786	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—FLT1—lung cancer	2.69e-05	0.000764	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—AKR1C1—lung cancer	2.69e-05	0.000761	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—PIK3CG—lung cancer	2.67e-05	0.000756	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—NOTCH3—lung cancer	2.64e-05	0.000747	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—APP—lung cancer	2.64e-05	0.000747	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—FGF9—lung cancer	2.61e-05	0.000741	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—UGT1A1—lung cancer	2.61e-05	0.000739	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—POMC—lung cancer	2.54e-05	0.00072	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GNG11—lung cancer	2.51e-05	0.000713	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—JUNB—lung cancer	2.5e-05	0.000708	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—PIK3CG—lung cancer	2.42e-05	0.000687	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ALDOA—lung cancer	2.39e-05	0.000679	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—PIK3CD—lung cancer	2.35e-05	0.000665	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—NCOA3—lung cancer	2.32e-05	0.000659	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—POMC—lung cancer	2.31e-05	0.000654	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—STK11—lung cancer	2.27e-05	0.000643	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ABCG2—lung cancer	2.26e-05	0.000641	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ADCY1—lung cancer	2.26e-05	0.000641	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—IL6R—lung cancer	2.25e-05	0.000638	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ENO2—lung cancer	2.22e-05	0.000629	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—HPGDS—lung cancer	2.22e-05	0.000629	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PPP2R1B—lung cancer	2.2e-05	0.000625	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—FOXO3—lung cancer	2.19e-05	0.00062	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GSTT1—lung cancer	2.15e-05	0.00061	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—MAP2K1—lung cancer	2.14e-05	0.000608	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—PIK3CD—lung cancer	2.13e-05	0.000604	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CYP2A6—lung cancer	2.13e-05	0.000603	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GCLC—lung cancer	2.13e-05	0.000603	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—AVP—lung cancer	2.05e-05	0.000581	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—PIK3CB—lung cancer	2.04e-05	0.00058	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ENO1—lung cancer	2.01e-05	0.000571	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IGF1R—lung cancer	1.97e-05	0.00056	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—CXCL8—lung cancer	1.96e-05	0.000557	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—HES1—lung cancer	1.94e-05	0.00055	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—RAF1—lung cancer	1.9e-05	0.000539	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—IL2—lung cancer	1.88e-05	0.000532	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—PIK3CB—lung cancer	1.86e-05	0.000526	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CYP2E1—lung cancer	1.81e-05	0.000512	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—NQO1—lung cancer	1.79e-05	0.000507	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—CXCL8—lung cancer	1.78e-05	0.000506	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ERBB3—lung cancer	1.77e-05	0.000503	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—IL2—lung cancer	1.7e-05	0.000483	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—TERT—lung cancer	1.7e-05	0.000482	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—FGFR1—lung cancer	1.65e-05	0.000468	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—HIF1A—lung cancer	1.62e-05	0.000461	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—STK11—lung cancer	1.61e-05	0.000457	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—APOA1—lung cancer	1.57e-05	0.000445	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—KDR—lung cancer	1.55e-05	0.000441	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GSTP1—lung cancer	1.49e-05	0.000423	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CAT—lung cancer	1.45e-05	0.000411	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—APC—lung cancer	1.43e-05	0.000406	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PIK3CG—lung cancer	1.43e-05	0.000406	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—KIT—lung cancer	1.43e-05	0.000406	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—NRAS—lung cancer	1.43e-05	0.000406	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—EGF—lung cancer	1.41e-05	0.000401	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ABCB1—lung cancer	1.41e-05	0.0004	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—TYMS—lung cancer	1.39e-05	0.000393	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—MAPK3—lung cancer	1.37e-05	0.000389	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—GSTM1—lung cancer	1.37e-05	0.000388	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—POMC—lung cancer	1.36e-05	0.000386	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—BRAF—lung cancer	1.35e-05	0.000381	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IL6R—lung cancer	1.33e-05	0.000377	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CREBBP—lung cancer	1.33e-05	0.000376	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—EGFR—lung cancer	1.3e-05	0.00037	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CYP1A1—lung cancer	1.3e-05	0.000368	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ERCC2—lung cancer	1.29e-05	0.000365	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MAP2K1—lung cancer	1.27e-05	0.000359	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PIK3CD—lung cancer	1.26e-05	0.000357	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	1.25e-05	0.000353	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—KRAS—lung cancer	1.23e-05	0.000349	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—PIK3CA—lung cancer	1.13e-05	0.000321	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MDM2—lung cancer	1.13e-05	0.00032	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—RAF1—lung cancer	1.12e-05	0.000318	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—APOA1—lung cancer	1.11e-05	0.000316	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—ERBB2—lung cancer	1.11e-05	0.000315	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PIK3CB—lung cancer	1.1e-05	0.000311	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MTOR—lung cancer	1.1e-05	0.000311	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CXCL8—lung cancer	1.05e-05	0.000299	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—HRAS—lung cancer	1.05e-05	0.000297	CbGpPWpGaD
Hydroxyzine—HRH1—GPCR downstream signaling—AKT1—lung cancer	1.02e-05	0.000289	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PIK3CG—lung cancer	1.02e-05	0.000288	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CASP3—lung cancer	1.01e-05	0.000286	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IL2—lung cancer	1.01e-05	0.000286	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—IL6—lung cancer	1e-05	0.000284	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CCND1—lung cancer	9.82e-06	0.000278	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—JUN—lung cancer	9.8e-06	0.000278	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—POMC—lung cancer	9.68e-06	0.000274	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MMP9—lung cancer	9.53e-06	0.00027	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—CDKN1A—lung cancer	9.5e-06	0.000269	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PTEN—lung cancer	9.48e-06	0.000269	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—CREBBP—lung cancer	9.43e-06	0.000267	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling by GPCR—AKT1—lung cancer	9.24e-06	0.000262	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—EP300—lung cancer	9.04e-06	0.000256	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PIK3CD—lung cancer	8.94e-06	0.000253	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—ALB—lung cancer	8.82e-06	0.00025	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—SRC—lung cancer	8.79e-06	0.000249	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—VEGFA—lung cancer	8.56e-06	0.000243	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—STAT3—lung cancer	8.48e-06	0.00024	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—NRAS—lung cancer	8.45e-06	0.00024	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MAPK3—lung cancer	8.1e-06	0.00023	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—MYC—lung cancer	7.88e-06	0.000223	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PIK3CB—lung cancer	7.79e-06	0.000221	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PTGS2—lung cancer	7.72e-06	0.000219	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—EGFR—lung cancer	7.7e-06	0.000218	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—KRAS—lung cancer	7.28e-06	0.000206	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PTEN—lung cancer	6.73e-06	0.000191	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—PIK3CA—lung cancer	6.69e-06	0.00019	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—TP53—lung cancer	6.47e-06	0.000183	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—EP300—lung cancer	6.42e-06	0.000182	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—HRAS—lung cancer	6.19e-06	0.000175	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—IL6—lung cancer	5.92e-06	0.000168	CbGpPWpGaD
Hydroxyzine—HRH1—Signaling Pathways—AKT1—lung cancer	5.46e-06	0.000155	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—PIK3CA—lung cancer	4.75e-06	0.000135	CbGpPWpGaD
Hydroxyzine—CYP2D6—Metabolism—AKT1—lung cancer	3.88e-06	0.00011	CbGpPWpGaD
